Dalfampridine and Dizziness aggravated - a phase IV clinical study of FDA data

Summary:

Dizziness aggravated is reported as a side effect among people who take Dalfampridine (dalfampridine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Baclofen, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Dizziness aggravated when taking Dalfampridine. It is created by eHealthMe based on reports of 9,652 people who have side effects when taking Dalfampridine from the FDA, and is updated regularly.

What is Dalfampridine?

Dalfampridine has active ingredients of dalfampridine. eHealthMe is studying from 9,658 Dalfampridine users. Check the latest studies of Dalfampridine.

What is Dizziness aggravated?

Dizziness aggravated is found to be associated with 2,740 drugs and 971 conditions by eHealthMe. Check the latest studies of Dizziness aggravated.

On Jul, 11, 2026

9,652 people reported to have side effects when taking Dalfampridine.
Among them, 674 people (6.98%) have Dizziness aggravated.

Could Dalfampridine cause Dizziness aggravated?

Among these 674 people:

How long have people been on Dalfampridine when they have Dizziness aggravated? *

Click here to view more results

What is the gender of people who have Dizziness aggravated when taking Dalfampridine? *

Click here to view

What is the age of people who have Dizziness aggravated when taking Dalfampridine? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Dalfampridine and have Dizziness aggravated?

- Check whether Dizziness aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dalfampridine:

Dalfampridine (9,658 reports)

Dizziness aggravated treatments and more:

Dizziness aggravated (302 reports)

How severe was Dizziness aggravated and when was it recovered:

Dizziness aggravated in Dalfampridine

Expand to all the drugs that have ingredients of dalfampridine:

Dizziness aggravated and drugs with ingredients of dalfampridine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dalfampridine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness aggravated:

Dizziness aggravated (2,741 drugs)

Browse all the conditions that are associated with Dizziness aggravated:

Dizziness aggravated (971 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dalfampridine (the active ingredients of Dalfampridine) and Dalfampridine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.